T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
626
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $114M | 0.02% |
2,988,007
+240,410
| +9% | +$10.6M |
|
|
K
627
DELISTED
Kellanova
K
| $114M | 0.02% |
1,726,475
-950,341
| -36% | -$64M |
|
628
Ovintiv
OVV
$17.2B
| $113M | 0.02% |
1,723,624
+1,038,048
| +151% | +$67.3M |
|
629
KT
KT
$9.07B
| $113M | 0.02% |
7,602,715
-83,300
| -1% | -$1.14M |
|
630
Steven Madden
SHOO
$3.48B
| $113M | 0.02% |
3,191,745
-11,577
| -0.4% | -$430K |
|
631
General Dynamics
GD
$106B
| $112M | 0.02% |
548,392
+59,865
| +12% | +$11.7M |
|
632
First American
FAF
$7.46B
| $112M | 0.02% |
2,168,895
+569,703
| +36% | +$31.2M |
|
633
SouthState Bank Corp
SSB
$10.8B
| $112M | 0.02% |
1,363,989
+153,926
| +13% | +$13M |
|
634
Qorvo
QRVO
$8.64B
| $112M | 0.02% |
1,450,413
-2,128,609
| -59% | -$170M |
|
635
National Bank Holdings
NBHC
$1.94B
| $112M | 0.02% |
2,961,607
-81,019
| -3% | -$3.19M |
|
636
HEICO Corp Class A
HEI.A
$37.5B
| $111M | 0.02% |
1,474,968
-1,807
| -0.1% | -$124K |
|
637
Marathon Petroleum
MPC
$98.5B
| $111M | 0.02% |
1,391,809
-34,932
| -2% | -$2.76M |
|
638
Mettler-Toledo International
MTD
$28.6B
| $111M | 0.02% |
182,373
-6,615
| -4% | -$3.89M |
|
|
TPH
639
DELISTED
Tri Pointe Homes
TPH
| $111M | 0.02% |
8,928,462
-209,241
| -2% | -$3.1M |
|
640
Tenaris
TS
$26.6B
| $110M | 0.02% |
3,277,083
+38,801
| +1% | +$1.35M |
|
641
Moog Inc Class A
MOG.A
$13.5B
| $110M | 0.02% |
1,277,653
+1,598
| +0.1% | +$126K |
|
|
THR
642
DELISTED
Thermon Group Holdings
THR
| $109M | 0.02% |
4,227,311
-21,061
| -0.5% | -$531K |
|
643
Grupo Aeroportuario del Sureste
ASR
$8.17B
| $109M | 0.02% |
530,834
+14,122
| +3% | +$2.59M |
|
644
AutoZone
AZO
$50.4B
| $108M | 0.02% |
139,682
-685
| -0.5% | -$504K |
|
645
Nektar Therapeutics
NKTR
$2.6B
| $108M | 0.02% |
118,283
-10,002
| -8% | -$8.54M |
|
|
TWOU
646
DELISTED
2U Inc
TWOU
| $108M | 0.02% |
47,903
+7,806
| +19% | +$19.3M |
|
647
Myers Industries
MYE
$1.26B
| $108M | 0.02% |
4,638,606
-78,294
| -2% | -$1.68M |
|
648
NovoCure
NVCR
$2.04B
| $108M | 0.02% |
2,055,136
+1,373,617
| +202% | +$54.7M |
|
649
Madrigal Pharmaceuticals
MDGL
$12.3B
| $107M | 0.02% |
500,877
-67,251
| -12% | -$16.9M |
|
650
Mine Safety
MSA
$7.3B
| $107M | 0.02% |
1,003,871
-85,809
| -8% | -$8.67M |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.